Alpha-Stim® M

Non-drug PainRelief is Possible

Alpha-Stim M is an FDA cleared, non-drug, non-surgical medical device for acute, chronic and post-traumatic pain relief, along with being able to treat the anxiety, insomnia, and depression* that can sometimes accompany pain.

*FDA cleared for anxiety, insomnia and pain only, with approval for depression outside of the United States.

Alpha-Stim M Features

Pain Relief Device Proven to
Reduce Acute & Chronic Pain

Pain reduced graphic

Severe Pain Reduction

In a study of patients with severe pain, Alpha-Stim M significantly reduced pain by an average of 71% after only five treatments.1
decrease in pain graphics

Decrease in Post-Traumatic Pain

In a post-traumatic pain study, 56% of patients at 3 months and 85% at 6 months were somewhat or very satisfied with the device for reducing pain levels. 2

improved function graphic

Improved
Function

One study found that chronic pain patients using Alpha-Stim reported significantly improved functionality over those receiving the usual care. 3
better than drugs graphic

Better than
drug-treatments

When compared to pain relief responses from patients using Vicodin and OxyContin, patients self-reported greater reductions in pain with Alpha-Stim.4

Two Separate Modalities

The Alpha-Stim M includes handheld Smart Probes or AS-Trode self-adhesive electrodes for site-specific MET pain therapy, as well as earclips that provide cranial electrotherapy stimulation (CES)—to relieve common comorbidities associated with pain, including anxiety, insomnia, and depression.

Alpha Stim M
Alpha Stim M
overall decrease in anxiety

Overall Decrease in Anxiety

In clinical trials, patients reported an average of 61% less anxiety immediately after using the CES therapy. After 5 weeks, that average was 94%.5
increased sleep time

Increased Sleep Time

After only 5 Alpha-Stim insomnia treatments, military service members with insomnia reported an increase of 43 minutes of sleep. 6
decrease in depression

Decrease in Depression

In clinical trials, Alpha-Stim recipients reported an 82% decrease of ≥ 50% or greater in depression scores after five weeks using the CES therapy. 7

Take charge of Your life

Alpha-Stim M is an FDA cleared non-drug, non-surgical device designed to relieve acute, chronic, and post-traumatic pain, along with anxiety, insomnia, and depression.

Compare Alpha-Stim vs. TENS Therapy for Pain Relief

Both Alpha-Stim and transcutaneous electrical nerve stimulation (TENS) units are used to provide drug-free pain treatment, but there is a big difference in what they do and how they perform.

And while they both provide pain relief via an electrical device, that’s where the similarities end.

Many choose a TENS unit at first because it can be quick to initially reduce some pain; however, the results are usually short-term. Conversely, the effects of Alpha-Stim are not only fast-acting but long-lasting and cumulative, for more sustainable pain relief over time. 

Learn more about the differences between Alpha-Stim and TENS here >

Alpha-Stim vs. TENS Therapy for Pain Relief

Both Alpha-Stim and transcutaneous electrical nerve stimulation (TENS) units are used to provide drug-free pain treatment, but there is a big difference in what they do and how they perform.

And while they both provide pain relief via an electrical device, that’s where the similarities end.

Many choose a TENS unit at first because it can be quick to initially reduce some pain; however, the results are usually short-term. Conversely, the effects of Alpha-Stim are not only fast-acting but long-lasting and cumulative, for more sustainable pain relief over time. 

Learn more about the differences between Alpha-Stim and TENS here >

A Technology Patients & Providers Trust

Alpha-Stim has been helping hundreds of thousands of people take charge of their anxiety, insomnia and pain. Alpha-Stim technology has led the way with innovative non-drug medical devices. Alpha-Stim AID and Alpha-Stim M devices are highly praised by both patients and providers.

TAKE CHARGE OF YOUR LIFE WITH ALPH-STIM

telehealth

Visit

See if Alpha-Stim is right for you via a telehealth visit with a licensed healthcare provider

shop

online

Purchase Alpha-Stim devices and accessories in our online store

talk with

our team

Speak with a
representative on the
phone to learn more

Commonly Asked Questions about Alpha-Stim M

We’ve gotten a few questions over the years about how Alpha-Stim M. See below for some of our most common questions and answers. 

Is Alpha-Stim a VNS device?

No. Alpha-Stim is a CES device. Due to the similarity in using an electrical current or earclip electrode application, Alpha-Stim can commonly be misidentified as a VNS device or auricular vagus nerve stimulation (aVNS) devices. And while Alpha-Stim does interact with the vagus nerve, there are key differences in the types of stimulation Alpha-Stim utilizes and the brain regions it targets. 

Learn more about the differences here.

Yes.

Alpha-Stim isn’t specifically designed to target the vagus nerve like dedicated vagus nerve stimulation (VNS) devices. However, its cranial electrotherapy stimulation (CES) does engage neural pathways that include vagal function (the vagus nerve), which may contribute to some of the clinical benefits seen with the device. 

To better understand how Alpha-Stim works, Ryan Gober, PhD, the Medical Science Liaison at Electromedical Products International, explains:

“Alpha-Stim uses a low intensity, patented waveform delivered through bilateral earclip electrodes to modulate cortical activity in the temporal lobe of the brain and to stimulate nearby key cranial nerves, including the vagus, trigeminal, and vestibulocochlear nerves that project to deeper subcortical brain structures. Through these two synergistic mechanisms, Alpha-Stim has been shown to modulate activity in the default mode network (DMN), which is widely reported to exhibit altered connectivity in a number of mental health conditions, including anxiety and insomnia.”

Watch how Alpha-Stim CES works in this quick video.

Read more in this blog!

The short answer? No. See why below.

VNS devices are designed specifically to target the vagus nerve, whereas Alpha-Stim works in a broader capacity through cranial electrotherapy stimulation (CES) delivered via the earlobes. This approach interacts with vagal pathways along with other cranial nerve networks, which is part of why Alpha-Stim is FDA-cleared for the treatment of anxiety, insomnia, and pain only, with approval for depression outside of the United States.

To better understand how Alpha-Stim works, Ryan Gober, PhD, the Medical Science Liaison at Electromedical Products International, explains:

“Alpha-Stim uses a low intensity, patented waveform delivered through bilateral earclip electrodes to modulate cortical activity in the temporal lobe of the brain and to stimulate nearby key cranial nerves, including the vagus, trigeminal, and vestibulocochlear nerves that project to deeper subcortical brain structures. Through these two synergistic mechanisms, Alpha-Stim has been shown to modulate activity in the default mode network (DMN), which is widely reported to exhibit altered connectivity in a number of mental health conditions, including anxiety and insomnia.”

Read more in this blog!

Vagus nerve stimulation (VNS) and VNS devices are often promoted for improving mood, emotional regulation, depression, and pain.

Alpha-Stim does interact with the vagus nerve, but there are key differences in the types of stimulation Alpha-Stim utilizes and the brain regions it targets.

  • Alpha-Stim delivers its patented cranial electrotherapy stimulation (CES) waveform through small clips on both earlobes. While the stimulation begins at the ear, the resulting electric fields extend beyond the clip sites to influence nearby cranial nerves, including the auricular branch of the vagus nerve.

     

  • What sets Alpha-Stim apart from a VNS device is that its fields don’t stop at the nerves outside the skull; they also pass through the bone to reach cortical layers of the brain. This direct brain engagement allows Alpha-Stim to modulate activity in brain regions such as the temporal lobe and in broader brain networks that are often dysregulated in anxiety and insomnia. 

  • By influencing both cranial nerves and cortical circuits, Alpha-Stim offers a distinct mechanism that helps normalize signaling in functional networks tied to these conditions.

Read more in this blog!

Regulatory authorization differs across VNS and non-VNS devices. Alpha-Stim is FDA-cleared (Class II) with defined, labeled indications, whereas other non-invasive products are often marketed in the United States solely as general-wellness devices (GWDs) and are not cleared to treat medical conditions. Alpha-Stim CES is cleared for the treatment of anxiety and insomnia, and Alpha-Stim M’s  MET technology is cleared for pain management. 

In practical terms, FDA clearance means the device has been reviewed in accordance with applicable regulatory requirements for specific medical indications, and the manufacturer has provided supporting evidence—including performance testing and clinical data—demonstrating that the device meets FDA expectations for safety, performance, and labeling. In contrast, general wellness products are not reviewed or cleared by the FDA for specific medical claims or indications.

Always verify each device’s clearance, labeling, and supporting evidence when choosing a treatment option.

As such, Alpha-Stim offers a unique combination of mechanistic overlap with vagus nerve–targeting devices and the regulatory assurance of FDA clearance for clinical use. (Outside the United States, Alpha-Stim is approved for treating anxiety, insomnia, and pain, as well as depression.)

In conclusion, clinical research suggests Alpha-Stim CES works via a multimodal mechanism involving indirect stimulation of the vagus nerve as well as cortical brain regions that have been linked to anxiety and insomnia.

Moreover, Alpha-Stim is evidence-based, with numerous clinical studies supporting FDA clearance to treat symptoms of anxiety and insomnia as reflected in the device’s labeling. This combined stimulation of cranial nerves and cortical brain regions, along with differences in regulatory authorization, distinguishes Alpha-Stim from devices focused solely on non-invasive VNS/aVNS.

Get more information here

 Neuropathy refers to damage or dysfunction of peripheral nerves that can result in symptoms such as tingling, burning, numbness, and pain.

While Alpha-Stim is not FDA-cleared to treat the underlying cause of neuropathy, it is FDA-cleared to treat acute, post-traumatic, and chronic pain in adults.

This means that although Alpha-Stim does not address the nerve damage itself, it can be used as part of a broader management plan to help reduce the pain associated with neuropathy.

Get more information here >

If you’re considering stacking Alpha-Stim with another device, pause. 

Alpha-Stim is FDA-cleared to treat anxiety, insomnia, and pain, making it a strong primary treatment option. You can use Alpha-Stim along with other treatment modalities, but using it along with a VNS device or other CES device is not necessary. 

See why you don’t need a VNS device and Alpha-Stim >

Alpha-Stim is a great option to use to complement TMS though! See why here. 

Speak with your healthcare provider before using Alpha-Stim alongside other modalities or treatments. There has been no evidence of drug interaction in 40 years of research and use of Alpha-Stim. Medication change is a decision that should be discussed with your healthcare practitioner.

Sources:

  • 1 Holubec, Jerry T. Cumulative response from cranial electrotherapy stimulation (CES) for chronic pain. Practical Pain Management. 2009; 9(9):80-83..

  • 2 Tan, Gabriel, Rintala, Diana, Jensen, Mark P., Richards, J. Scott, Holmes, Sally Ann, Parachuri, Rama, Lashgari-Saegh, Shamsi and Price, Larry R. Efficacy of cranial electrotherapy stimulation for neuropathic pain following spinal cord injury: a multi-site randomized controlled trial with a secondary 6-month open-label phase. The Journal of Spinal Cord Medicine. 2011; 34(3):285-296.

  • 3 Taylor AG, Anderson JG, Riedel SL, et al. Cranial Electrotherapy Stimulation improves symptoms and functional status in individuals with fibromyalgia. Pain Management Nursing. 2013 Dec; 14(4):327-335.

  • 4 Kirsch, D.L., Price, L.R., Nichols, F., Marksberry, J.A., & Platoni, K.T. Military Service Member and Veteran Self-Reports of Efficacy of Cranial Electrotherapy Stimulation for Anxiety, PTSD, Insomnia, and Depression. (2014). The Army Medical Department Journal, 46-54.

  • 5 Barclay TH, Barclay RD. A clinical Trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders. 2014;164:171-177. Presented at the American Psychological Association National Conference, Honolulu, July 2013.

  • 6 Lande RG, Gragnani C. Efficacy of Cranial Electric Stimulation for the treatment of insomnia: A randomized pilot study. Complementary Therapies in Medicine. 2013; 21(1):8-13.
  • 7 Barclay TH, Barclay RD. A clinical Trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders. 2014; 164:171-177. Presented at the American Psychological Association National Conference, Honolulu, July 2013.
0
    0
    Your Cart
    Your cart is emptyReturn to Shop